Urology
Prostate, bladder and kidney cancer, benign prostatic hyperplasia, stone disease, incontinence, andrology and robotic surgery.
Published issues
- What's next in urology — November 16, 2026
Three upcoming dates in urology, from December 2026 to March 2027: a company-announced presentation of PIVOT-006, a phase 3 trial in intermediate-risk non-muscle-invasive bladder cancer (NMIBC), and the ASCO GU and EAU…
🎧 ListenAudio newscast · 3:37 min - Monthly urology bulletin — November 6, 2026
Period covered: October 7 to November 6, 2026. The month was dominated by the ESMO Congress (Madrid, October 23–27), with one positive and one negative trial in muscle-invasive bladder cancer (MIBC) and long-term…
🎧 ListenAudio newscast · 5:03 min - What's next in urology — October 16, 2026
This edition covers what is coming in urology between mid-October 2026 and March 2027: two pending FDA decisions (muscle-invasive bladder cancer and metastatic castration-sensitive prostate cancer) and the three…
🎧 ListenAudio newscast · 4:20 min - Monthly urology bulletin — October 6, 2026
Period covered: September 6 to October 6, 2026. The month was dominated by urologic oncology (the 2026 ASTRO Annual Meeting and two regulatory decisions in muscle-invasive bladder cancer) and by three new guidelines. We…
🎧 ListenAudio newscast · 5:30 min - Monthly urology bulletin — September 29, 2026
Period covered: August 30 to September 29, 2026. A month dominated by urologic oncology (ASTRO in Boston, an FDA approval in kidney cancer and a European regulatory step in bladder cancer), with regulatory news in…
🎧 ListenAudio newscast · 6:40 min